Drug Markets/Metformin Hydrochloride Extended-Release Tablets

Metformin Hydrochloride Extended-Release Tablets

4 NDCs across 1 manufacturer|4 Generic,0 Brand

▸ More about this market

Metformin Hydrochloride Extended-Release Tablets is available as 4 NDCs from 1 manufacturer (4 generic, 0 brand), with NADAC prices from $0.16 to $0.34 per EA — the most expensive product costs about 2.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

4G / 0B

Manufacturers

1

competing in market

Price Spread

$0.16 – $0.34

per EA

7d Activity

3↑1↓0 flat

avg +4.8% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

How many Metformin Hydrochloride Extended-Release Tablets products are on the market?

The Metformin Hydrochloride Extended-Release Tablets drug market contains 4 NDCs from 1 manufacturer — 4 generic and 0 brand products.

What is the price range for Metformin Hydrochloride Extended-Release Tablets?

NADAC reference prices for Metformin Hydrochloride Extended-Release Tablets range from $0.1644 to $0.3357 per EA — the most expensive product costs about 2.0× the cheapest.

Which manufacturers make Metformin Hydrochloride Extended-Release Tablets?

1 manufacturer lists Metformin Hydrochloride Extended-Release Tablets in NADAC. Ranked by number of NDCs, the largest are ScieGen Pharmaceuticals, Inc. (4).

How has the price of Metformin Hydrochloride Extended-Release Tablets changed recently?

Over the past 7 days, 3 Metformin Hydrochloride Extended-Release Tablets NDCs rose and 1 fell, with a market-wide average change of +4.8%.